UBE3A and Angelman syndrome: We sought to assess the efficacy of Ube3a-as ASO and Snord115 ASO in our new mouse model of Angelman syndrome across brain regions and over time by systematically determining the total Ube3a protein, Ube3a mRNA, and Ube3a-ATS levels.